Development of Collaboration Compounds. Bayer shall have the sole right and responsibility to conduct Development of Collaboration Compounds, either itself or through its Affiliates or licensees on its behalf and at its expense, with the right to file Approval Applications for obtaining and maintaining Regulatory Approval of Products as soon as reasonably practicable. Upon deciding to commence Development on a Collaboration Compound, Bayer shall notify the LLC in writing of such decision. If requested by Bayer in writing, the LLC shall provide Bayer reasonable assistance, at Bayer's expense, in conducting such Development efforts.
Appears in 2 contracts
Sources: Collaboration Agreement (Exelixis Inc), Collaboration Agreement (Exelixis Inc)